<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Proc Natl Acad Sci U S A</journal-id>
<journal-id journal-id-type="iso-abbrev">Proc. Natl. Acad. Sci. U.S.A</journal-id>
<journal-id journal-id-type="hwp">pnas</journal-id>
<journal-id journal-id-type="pmc">pnas</journal-id>
<journal-id journal-id-type="publisher-id">PNAS</journal-id>
<journal-title-group>
<journal-title>Proceedings of the National Academy of Sciences of the United States of America</journal-title>
</journal-title-group>
<issn pub-type="ppub">0027-8424</issn>
<issn pub-type="epub">1091-6490</issn>
<publisher>
<publisher-name>National Academy of Sciences</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30352856</article-id>
<article-id pub-id-type="pmc">6233096</article-id>
<article-id pub-id-type="publisher-id">201803177</article-id>
<article-id pub-id-type="doi">10.1073/pnas.1803177115</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>PNAS Plus</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Biological Sciences</subject>
<subj-group>
<subject>Genetics</subject>
</subj-group>
</subj-group>
<series-title>PNAS Plus</series-title>
</article-categories>
<title-group>
<article-title>BRCA1 ensures genome integrity by eliminating estrogen-induced pathological topoisomerase II–DNA complexes</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Sasanuma</surname>
<given-names>Hiroyuki</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="author-notes" rid="fn1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="cor1">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tsuda</surname>
<given-names>Masataka</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
<xref ref-type="author-notes" rid="fn1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Morimoto</surname>
<given-names>Suguru</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="author-notes" rid="fn1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Saha</surname>
<given-names>Liton Kumar</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rahman</surname>
<given-names>Md Maminur</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kiyooka</surname>
<given-names>Yusuke</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fujiike</surname>
<given-names>Haruna</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cherniack</surname>
<given-names>Andrew D.</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>c</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Itou</surname>
<given-names>Junji</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>d</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Callen Moreu</surname>
<given-names>Elsa</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>e</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Toi</surname>
<given-names>Masakazu</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>d</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nakada</surname>
<given-names>Shinichiro</given-names>
</name>
<xref ref-type="aff" rid="aff6">
<sup>f</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0001-9223-4186</contrib-id>
<name>
<surname>Tanaka</surname>
<given-names>Hisashi</given-names>
</name>
<xref ref-type="aff" rid="aff7">
<sup>g</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tsutsui</surname>
<given-names>Ken</given-names>
</name>
<xref ref-type="aff" rid="aff8">
<sup>h</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yamada</surname>
<given-names>Shintaro</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nussenzweig</surname>
<given-names>Andre</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>e</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Takeda</surname>
<given-names>Shunichi</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="corresp" rid="cor1">
<sup>2</sup>
</xref>
</contrib>
<aff id="aff1"><sup>a</sup>Department of Radiation Genetics, Graduate School of Medicine, <institution>Kyoto University</institution>, 606-8501 Kyoto, <country>Japan</country>;</aff>
<aff id="aff2"><sup>b</sup>Department of Mathematical and Life Sciences, Graduate School of Science, <institution>Hiroshima University</institution>, 739-8526 Higashi-Hiroshima, <country>Japan</country>;</aff>
<aff id="aff3"><sup>c</sup><institution>The Eli and Edythe L. Broad Institute of the Massachusetts Institute of Technology and Harvard University</institution>, Cambridge, <addr-line>MA</addr-line> 02142;</aff>
<aff id="aff4"><sup>d</sup>Department of Breast Surgery, Graduate School of Medicine, <institution>Kyoto University</institution>, 606-8507 Kyoto, <country>Japan</country>;</aff>
<aff id="aff5"><sup>e</sup>Laboratory of Genome Integrity, National Cancer Institute, <institution>NIH</institution>, Bethesda, <addr-line>MD</addr-line> 20892;</aff>
<aff id="aff6"><sup>f</sup>Department of Bioregulation and Cellular Response, Graduate School of Medicine, <institution>Osaka University</institution>, Suita, 565-0871 Osaka, <country>Japan</country>;</aff>
<aff id="aff7"><sup>g</sup>Department of Surgery, <institution>Cedars-Sinai Medical Center</institution>, West Hollywood, <addr-line>CA</addr-line> 90048;</aff>
<aff id="aff8"><sup>h</sup>Department of Neurogenomics, Graduate School of Medicine, Dentistry and Pharmaceutical Science, <institution>Okayama University</institution>, 700-8558 Okayama, <country>Japan</country></aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><sup>2</sup>To whom correspondence may be addressed. Email: <email>hiroysasa@rg.med.kyoto-u.ac.jp</email> or <email>stakeda@rg.med.kyoto-u.ac.jp</email>.</corresp>
<fn fn-type="edited-by">
<p>Edited by Maria Jasin, Memorial Sloan Kettering Cancer Center, New York, NY, and approved October 2, 2018 (received for review April 3, 2018)</p>
</fn>
<fn fn-type="con">
<p>Author contributions: H.S., S.M., J.I., M. Toi, H.T., A.N., and S.T. designed research; H.S., M. Tsuda, S.M., L.K.S., M.M.R., Y.K., H.F., J.I., and S.N. performed research; E.C.M., M. Toi, K.T., and A.N. contributed new reagents/analytic tools; H.S., M. Tsuda, S.M., A.D.C., J.I., S.Y., and S.T. analyzed data; and H.S., H.T., A.N., and S.T. wrote the paper.</p>
</fn>
<fn fn-type="equal" id="fn1">
<p><sup>1</sup>H.S., M. Tsuda, and S.M. contributed equally to this work.</p>
</fn>
<fn fn-type="COI-statement">
<p>The authors declare no conflict of interest.</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<day>6</day>
<month>11</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>23</day>
<month>10</month>
<year>2018</year>
</pub-date>
<volume>115</volume>
<issue>45</issue>
<fpage>E10642</fpage>
<lpage>E10651</lpage>
<permissions>
<copyright-year>2018</copyright-year>
<license>
<license-p>Published under the <ext-link ext-link-type="uri" xlink:href="http://www.pnas.org/site/aboutpnas/licenses.xhtml">PNAS license</ext-link>.</license-p>
</license>
</permissions>
<self-uri xlink:href="pnas.201803177.pdf" xlink:title="pdf"></self-uri>
<abstract abstract-type="executive-summary">
<title>Significance</title>
<p>BRCA1 plays a key role in homology-directed repair (HDR) in S/G<sub>2</sub>-phase cells. It remains unclear why BRCA1 mutation carriers develop cancer predominantly in breast and ovarian tissues. We revealed that a physiological concentration (10 nM) of estrogens efficiently induce TOP2β-dependent DSBs in the absence of BRCA1 in breast cancer cells arrested in G<sub>1</sub> phase. This genotoxicity was confirmed also in G<sub>0</sub>/G<sub>1</sub>-phase epithelial cells of mouse mammary glands. These findings indicated that BRCA1 contributes to DSB repair independent of HDR. Our data suggested that BRCA1 promotes the removal of TOP2 adducts from DSBs by the nucleolytic activity of MRE11 for subsequent DSB repair by nonhomologous end-joining. This function of BRCA1 may help explain the female-organ-specific carcinogenesis of BRCA1-mutation carriers.</p>
</abstract>
<abstract>
<p>Women having BRCA1 germ-line mutations develop cancer in breast and ovary, estrogen-regulated tissues, with high penetrance. Binding of estrogens to the estrogen receptor (ER) transiently induces DNA double-strand breaks (DSBs) by topoisomerase II (TOP2) and controls gene transcription. TOP2 resolves catenated DNA by transiently generating DSBs, TOP2-cleavage complexes (TOP2ccs), where TOP2 covalently binds to 5′ ends of DSBs. TOP2 frequently fails to complete its catalysis, leading to formation of pathological TOP2ccs. We have previously shown that the endonucleolytic activity of MRE11 plays a key role in removing 5′ TOP2 adducts in G<sub>1</sub> phase. We show here that BRCA1 promotes MRE11-mediated removal of TOP2 adducts in G<sub>1</sub> phase. We disrupted the <italic>BRCA1</italic> gene in <italic>53BP1</italic>-deficient ER-positive breast cancer and B cells. The loss of BRCA1 caused marked increases of pathological TOP2ccs in G<sub>1</sub> phase following exposure to etoposide, which generates pathological TOP2ccs. We conclude that BRCA1 promotes the removal of TOP2 adducts from DSB ends for subsequent nonhomologous end joining. <italic>BRCA1</italic>-deficient cells showed a decrease in etoposide-induced MRE11 foci in G<sub>1</sub> phase, suggesting that BRCA1 repairs pathological TOP2ccs by promoting the recruitment of MRE11 to TOP2cc sites. BRCA1 depletion also leads to the increase of unrepaired DSBs upon estrogen treatment both in vitro in G<sub>1</sub>-arrested breast cancer cells and in vivo in epithelial cells of mouse mammary glands. BRCA1 thus plays a critical role in removing pathological TOP2ccs induced by estrogens as well as etoposide. We propose that BRCA1 suppresses tumorigenesis by removing estrogen-induced pathological TOP2ccs throughout the cell cycle.</p>
</abstract>
<kwd-group>
<kwd>BRCA1</kwd>
<kwd>estradiol (E2)</kwd>
<kwd>topoisomerase II</kwd>
<kwd>HBOC syndrome</kwd>
<kwd>breast cancer</kwd>
</kwd-group>
<counts>
<page-count count="10"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>